S
Sequentia Biotech
Biotech & Life Sciences · Barcelona, Spain · Founded 2013
Sequentia Biotech developed MICK, a digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice MoreLess
Operator of a bioinformatics company intended to transform omics data into knowledge. The company collaborates with research centers, universities and businesses to offer cloud software, custom software and bioinformatics consulting services for healthcare, pharma, agriculture, industry and environment, enabling clients to utilize omics sciences for achieving a breakthrough in the fields of human health, agriculture and the environment. Keywords: Pharmaceuticals and Biotechnology, Bioinformatics, Bioinformatics Analysis, Bioinformatics Company, Bioinformatics Data, Bioinformatics Research, Bioinformatics System.
Company overview
Sequentia Biotech company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2013
- Headquarters
- Barcelona, Spain
- Employees
- 48
- Open positions
- None listed
- Dealroom signal
- 67.5
Valuation & funding
Sequentia Biotech funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Sep 2024 | $11M | $44M | Seventure Partners · EIC Fund | ↗ |
| GRANTOther financing | Oct 2021 | $2.2M | — | European Innovation Council | — |
| EARLY VCOther financing | Oct 2021 | $0 | — | EIC Fund | — |
| GRANTOther financing | Dec 2016 | $55K | — | European Innovation Council | — |
| SPINOUTOther financing | Apr 2013 | — | — | Centre for Genomic Regulation · Centre for Research in Agricultural Genomics | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $2.4M | 0% | 48 |
| 2025 | $2.4M | 0% | 47 |
| 2024 | $2.4M | 0% | 46 |
| 2023 | $2.4M | +26.4% | 38 |
| 2022 | $1.9M | — | — |
Growth signals
Sequentia Biotech website traffic
Latest recorded traffic for Sequentia Biotech is 2.6K monthly website visits, up 4% over the last three months. Sequentia Biotech's team grew 2.1% over the past year.
Comparisons
Sequentia Biotech compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Sequentia Biotech's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on Sequentia Biotech's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Sequentia Biotech has talent and traffic
team presence
In the news
Latest news about Sequentia Biotech
Recent press, funding announcements, and product moves mentioning Sequentia Biotech — open to read from the original sources.
Market sentiment
What the market is saying about Sequentia Biotech
An AI-synthesized read of the highest-engagement posts about Sequentia Biotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sequentia Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.